Search results
Showing 2611 to 2625 of 9128 results
Cimavax for treating wild-type EGFR-positive non-small-cell lung cancer [ID1259]
In development Reference number: GID-TA10225 Expected publication date: TBC
In development Reference number: GID-TA10248 Expected publication date: TBC
Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261]
In development Reference number: GID-TA10250 Expected publication date: TBC
Doxorubicin nanoparticles for previously treated advanced hepatocellular carcinoma [ID1314]
In development Reference number: GID-TA10251 Expected publication date: TBC
Awaiting development Reference number: GID-QS10038 Expected publication date: TBC
Awaiting development Reference number: GID-TA10438 Expected publication date: TBC
Awaiting development Reference number: GID-TA10439 Expected publication date: TBC
Awaiting development Reference number: GID-TA10665 Expected publication date: TBC
Ranibizumab port delivery system for treating diabetic macular oedema [ID6137]
Awaiting development Reference number: GID-TA11065 Expected publication date: TBC
Awaiting development Reference number: GID-TA11085 Expected publication date: TBC
Awaiting development Reference number: GID-QS10091 Expected publication date: TBC
Awaiting development Reference number: GID-QS10096 Expected publication date: TBC
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care
Awaiting development Reference number: GID-QS10144 Expected publication date: TBC
Awaiting development Reference number: GID-TA10198 Expected publication date: TBC
Awaiting development Reference number: GID-TA10787 Expected publication date: TBC